Autor:
Quezada, M.
Diaz, J.
Henriquez, S.
Bravo, M. L.
Aranda, E.
Oliva, B.
Villalon, M.
Kato, S.
Cuello, M. A.
Brosens, J. J.
Lange, C. A.
Owen, G. I.
2-Methoxyestradiol (2ME) is an endogenous metabolite of 17β-estradiol with antiangiogenic and antitumor properties, although its mechanisms of action remain unclear. Progestins in hormone replacement therapy increase the risk of breast cancer. Progesteron
Enlace original:
https://repositorio.uc.cl/handle/11534/27179https://repositorio.uc.cl/handle/11534/27179
Quezada, M.
,
Diaz, J.
,
Henriquez, S.
,
Bravo, M. L.
,
Aranda, E.
,
Oliva, B.
,
Villalon, M.
,
Kato, S.
,
Cuello, M. A.
,
Brosens, J. J.
,
Lange, C. A.
,
Owen, G. I.
,
[2-Methoxyestradiol inhibits progesterone-dependent tissue factor expression and activity in breast cancer cells]
,
2-Methoxyestradiol inhibits progesterone-dependent tissue factor expression and activity in breast cancer cells
